Autopsy report · NCT00754923
Sorafenib in Treating Non-Smokers or Former Light Smokers With Relapsed or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Cause of deathNo reason given
Life of this trial
- Ran for about 3 years 6 months before it stopped.
- 11 participants enrolled.
- Results were posted on the registry 2 years 2 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Sponsor type
- University, hospital or other
- Conditions
- Lung Cancer
- Interventions
- sorafenib
- Participants
- 11
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.